CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

While Eli Lilly’s LLY top-line continues to touch new sky highs thanks to its blockbuster GLP-1 medicines — Mounjaro (for ...

Insulin changed the way we treat and manage diabetes. Chemotherapy has precipitously reduced the mortality rate of certain ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...

As Wall Street puts April's tariff shakeout in the rearview mirror and indexes set record highs, investors remain wary of U.S ...

TUCKING into the final slice of her cheese feast pizza, Teresa Parent’s stomach grumbled. She might have just devoured a ...

Trend alert! Split dosing, stretch dosing, skip dosing, microdosing Ozempic… People are finding creative ways to use ...

Their most recent survey was conducted June 12 and 13, the first and second days of Israel’s strikes on Iran. Like previous ...

As the outpatient surgery landscape rapidly expands, anesthesia practices are undergoing a pivotal transformation. Ten anesthesia leaders joined Becker’s to discuss how their roles are shifting to ...

GLP-1 drugs like Ozempic® and Zepbound®, have gained significant attention in recent years for treating both diabetes and ...